Article
Mutation Changes in the preC/Core Promoter in HBeAg-Positive Patients With Chronic Hepatitis B During Interferon Therapy.
Medicine - 1 Feb 2016
Geng Yan, Wang Xiangling, Lu Xiaolan, Wu Xiaokang, Xu Nan, Han Lei, Xu Jiru
Abstract excerpt
To study the changes in 3 mutations related with hepatitis B e antigen (HBeAg) in patients with HBeAg-positive chronic hepatitis B (CHB) during interferon therapy.HBeAg seroconversion is a major therapeutic milestone for patients with HBeAg-positive CHB. The precore mutation G1896A and the basal core promoter mutations A1762T/G1764A are 3 important mutations that affect the expression of HBeAg; however, the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
